TW200907064A - Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains - Google Patents

Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains Download PDF

Info

Publication number
TW200907064A
TW200907064A TW96129626A TW96129626A TW200907064A TW 200907064 A TW200907064 A TW 200907064A TW 96129626 A TW96129626 A TW 96129626A TW 96129626 A TW96129626 A TW 96129626A TW 200907064 A TW200907064 A TW 200907064A
Authority
TW
Taiwan
Prior art keywords
english
chinese
name
test
strain
Prior art date
Application number
TW96129626A
Other languages
Chinese (zh)
Other versions
TWI384075B (en
Inventor
Chang-Phone Fung
Heung-Kei Siu
Feng-Yee Chang
Jung-Chung Lin
Te-Li Chen
Original Assignee
Univ Nat Yang Ming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Yang Ming filed Critical Univ Nat Yang Ming
Priority to TW96129626A priority Critical patent/TWI384075B/en
Publication of TW200907064A publication Critical patent/TW200907064A/en
Application granted granted Critical
Publication of TWI384075B publication Critical patent/TWI384075B/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a test kit for detecting Klebsiella pneumoniae virulent strain K1/K2 and use thereof.

Description

200907064 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種克雷伯氏肺炎桿菌毒性菌株K1/K2快速檢驗劑。 【先前技術】 克雷伯氏肺炎湖是革蘭氏陰性的桿g,隸>1於腸内g科,為-重 要的伺機性感染的病原菌。近2〇年來,一種新型的侵襲性克雷伯氏肺 (、 炎桿菌感染逐漸躍升為—個全球性輯興重要社區感染症。克雷伯氏 肺炎桿g引起的化膿性絲症、狂症以及相當比率域染,在 台灣它在革蘭氏陰性桿H巾居第二位。台灣的肝麟百分之八十由克 雷伯氏肺炎桿菌引起’以社區感染為主,非—般之院内感染,病程發 展急速並可能併發眼内炎而導致失明。流行病學分析最常發生在台灣 的血清型K1&K2二型’該二型菌株毒性最強,最容易轉移到眼球造 成嚴重的眼内炎’須將眼球摘除方能保命。目前台灣已有超過7〇例因 C 克氏菌肝膿癌造成終身眼盲的病例。_外的文獻皆指出嚴重的併發 症如眼内炎等之發生皆在克氏菌化膿性肝膿癌形成後 48-72小時之内 發生’因此臨床上若能及早鐘定出此二種毒性株,即刻更改治療方針, 施打較昂貴㈣三帶馳子帛素可驗_炎的_發生。 克氏菌所引起的化膿性肝膿癌為一新興的感染症,目前除了盛行於 亞洲國家及地區之外’歐鱗國亦_有相_文獻報導。而相關的 研九重點集巾在以分子生物學的方法找雜病@子,在以致病因子來 做聚合酶連鎖反應(polymerasechain咖如,pcR),以作為快速診斷 200907064 的方法,目前台灣大學的研究團隊雜找到_基因用來做pcR,但 僅月b測出ΚΙ ®株紅2母性菌株則無法湖,spCR的方法最快需 要準備天的時間’同B寸需要具備昂責的儀器及純熟的技術,且工作 煩殯’必須請專人操作。 .發明内容】 本發明之目社要是亟欲解決早期驗速鑑定克氏頻 及K2型之 毒性菌株以便能即 時提供私床醫師-個準確的答案以便及時治療化膿性肝膿癌所帶來 的併紐的問題。_外的文獻皆指出嚴重的併發症如眼内炎等之發 生白在克氏菌化膿性肝膿瘍形成後48_了2小時之内發生,因此如能在 極短的日年間内利用克氏菌毒性菌株kl/k2快速檢驗劑,於5分鐘内即 可測知該菌是否為毒性菌株,在臨床診斷及治療上將會得到重大突 破。 本發明為利用免疫色層分析(immunochromatogaphic test,ICT)之方法研 發克雷伯氏菌K1及K2型之毒性菌株之快速檢驗。 是以’本發明係關於一種克雷伯氏肺炎桿菌毒性菌株K1/K2的檢驗試 劑’其特徵包括一載體其上固定抗雷克伯氏肺炎桿菌毒性菌株K1/K2 200907064 本發明檢驗試劑中載體包括但不限於係硝酸纖維膜。為有利檢體流 動’載體可黏附於吸水塾片。 本發明檢驗試劑中標記物可顯示抗體與檢體之反應,該標記物包括但 不限於膠體金。 本發明檢驗試劑中抗體為任何動物對克雷伯氏菌K1及K2型毒性菌株之 抗體,其可與膠體金共軛產生共軛物,於較佳具體實施例為小鼠_a_kpl 膠體金共扼物(CGC)或小鼠-a-kp2膠體金共輛物。 本發明檢驗試劑中膠體金與抗體已結合並塗附於一體可擴散载體,形 成一膠體墊片。該膠體金墊片一面可黏附於載體,其另一面可黏附於 檢體墊片。 本發明係關於一種檢測克雷伯是肺炎桿菌毒性株K1/K2之方法,包括(a) 提供一檢體,及(b)將該檢體加入本發明之檢測試劑,及(c)觀察抗體與 檢體是否有聚集反應。 於本發明方法中,檢體係克雷伯氏肺炎桿菌毒性菌株K1或K2,會於遇 到抗體處形成一條實線。 於本發明方法中,檢驗試劑包括一控制線,用以表示試劑運作正常。 本發明方法,可用於任何包括檢體,但不限於臨床肝膿瘍檢體、腦脊 200907064 髓液或尿液檢測。 【實施方式】 實例1: 本發明為利用免疫色層分析(immunochromatogaphic test, ICT)之方法 研發克雷伯氏菌K1及K2型之毒性菌株之快速檢驗,其步驟如下: (一)、克雷伯氏菌Κ1及Κ2型之毒性菌株之抗血清的製備:以低劑量 之Κ1及Κ2型之毒性菌株在小鼠身上發免疫反應,同時加入二級抗體: 山羊-α-小鼠-IgG-HRP(Goat-a-mouse-IgG-HRP)以酵素免疫分析法 (enzyme-linked immunosorbent assay, ELISA)測定其效價,並將所得之抗 體以蛋白質A色層分析純化。 (一) 、喷膜及乾燥:將純化後的抗血清(小鼠_a_kpi及小鼠_a_kp2)稀 釋以噴膜機後嘴量固定至硝酸纖維膜(NC膜,長度為3〇cm),固定後將 置於恆溫恆濕無塵室内乾燥24小時後進行阻斷(bi〇cking)製程作業。 (二) 、膠體金的製備:取適量之抗血清抗體和膠體金(25nm)進行反 應結合及濃縮。將製備好的小鼠_a_kpi CGC及小鼠-a-kp2 CGC,以噴 量3.〇4/Cm以喷膜機固定在材質為玻璃纖維膠體金墊片上,恆溫恆濕箱 内以TEMP=37t:、RH=5%、乾燥30 分鐘。 (四)、試劑组裝作業:將硝酸纖維膜保護層撕下(圖一),黏貼硝 酸纖維膜(位置1),用手指指腹將硝’酸纖維膜確實壓合,確保頌酸纖維 膜黏貼牢固。再將吸水墊片保護層撕下,黏貼吸水墊片(位置2),用手 指指腹將Top pad壓合,確保Top pad黏貼牢固。確認Top pad上緣與 200907064 塑膠底卡上緣㈣。郷體金维置3)表_賴層撕下, 將裁切好的频金墊片沿著檢體墊片無處之保護層上緣黏貼。用手 指指腹將賴金料壓合,確轉體金墊片無牢固。輕麵金塾 片與雜纖維膜有重疊2±1職。最後撕下檢體糾保護層,將裁好的 檢體塾片沿歸底卡下緣對齊貼合(位置彳),手指指腹確實壓合。 霉認檢體墊片與膠體金墊片有重疊5±2mm。 將上述組裝㈣栽卡,賴紙裁城_麟條3細遍如的寬 度’ speed=6G進行裁切’裁切好後組裝試紙條至觸卡内,最後以銘 鉑袋以卧式包裝機包裝。 實例2 : 1、 將肝膿躲體以生理食躲稀釋拌㈣為彳铜之標本,(標本若為腦 ㈣液、尿液或其他體液則可不必稀釋,標本若為已培養好之克氏菌, 則先挑取2-3個菌落用生理食鹽水拌勻即可)。 2、 將試劑之包裝紙打開置於桌上’將待測之標本以微量吸管吸取丄滴 待測之標本滴入標本測試區(S-Weu)。 3、 再以《吸管娜本觸__祕純如却一油㈣3 滴待測之標本狀標本職區(S_well),3_5健_可判讀。 4、 判讀的準則如下: ⑴.若只有-雜紅色的線條出現在c帥騰ye。咖uine), 表示本試継作正常’但_試之標本並不是克氏菌,即使為克氏菌 亦非為毒性最強之K1或K2型菌株。 200907064 ⑵.若·上出現二«紅色猶條,—條㈣在c邮㈣另 外-條出現在i區(職e)或2區似㈣,即可判定簡株為Ki或 K2型菌株。 實例3: 挑取三種不同血清型(包細,K2及咖微2)的菌株測試結果:第 二圖中左側之試劑顯示為跡Κ1/Κ2型菌株,中側之試劑顯示為幻型 菌株,右側之試麵福K2型g株。本·已⑽統之血清分型法作 對照檢驗,結果並未發現與其他Η種不同血清型_株發生交又反應 (crossreaction),顯示本試劑之特異性(specificity)極高。 【圖式簡單說明】 圖一顯示試劑組裝之順序。 S —頁示—種不同血清型(包括幻,^ &n〇n_K1/K2)的菌株測試結果。 【主要元件符號說明】 1硝酸纖維膜 2吸水墊片 3膠體金墊片 4檢體墊片200907064 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a rapid test agent for Kjb Klebsiella virulent strain K1/K2. [Prior Art] Krebs pneumonia lake is a Gram-negative rod g, which is a pathogen of an opportunistic infection in the gut of the intestine. In the past two years, a new type of invasive Krebs' lung (the inflammatory infection has gradually increased to a global community-recovery important community infection. Klebsi's pneumonia g caused by suppurative silk disease, madness And a considerable ratio of domain dyeing, in Taiwan, it ranks second in the Gram-negative rod H. Eighty percent of Taiwan's liver lining is caused by Klebsiella pneumoniae's community-based infection, non-like In-hospital infection, rapid development of the disease and may be accompanied by endophthalmitis leading to blindness. Epidemiological analysis most commonly occurs in Taiwan's serotype K1 & K2 type 2 'The second type of strain is the most toxic, most likely to transfer to the eye to cause serious eyes Endophthalmia must be removed from the eyeball to save life. At present, there are more than 7 cases of life-long blindness caused by C. comatus liver pus cancer in Taiwan. The external literature points out serious complications such as endophthalmitis. The occurrence occurs within 48-72 hours after the formation of Klebsiella purulent hepatic sputum cancer. Therefore, if the two virulent strains are determined early in clinical practice, the treatment policy is changed immediately, and the application is more expensive.帛素 can be tested _ inflammation _ occurs. Suppurative liver and sputum cancer caused by Klebsiella is an emerging infectious disease. At present, in addition to prevailing in Asian countries and regions, 'European countries also have _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The method of learning to find miscellaneous disease @子, in the case of the cause of the polymerase chain reaction (polymerasechain coffee, such as pcR), as a rapid diagnosis of 200907064 method, the current research team of Taiwan University found _ gene used to do pcR However, only the monthly b measured ΚΙ ® plant red 2 mother strain can not be lake, spCR method needs to prepare for the fastest time 'with B inch need to have the instrument and skillful technology, and work irritated 'must please Specialized operation. SUMMARY OF THE INVENTION The object of the present invention is to solve the early test speed identification of the K-frequency and K2 type of virulent strain so that the private bed doctor can be provided immediately - an accurate answer for timely treatment of suppurative hepatic carcinoma The problems brought by the new _. The external literature pointed out that serious complications such as endophthalmitis occur within 48 hours after the formation of Klebsiella purulent hepatic abscess, so if In the short day-to-day period, the K. pneumoniae strain kl/k2 rapid test agent can be used to detect whether the bacteria is a virulent strain within 5 minutes, and a major breakthrough will be obtained in clinical diagnosis and treatment. A method for the development of a virulence strain of Klebsiella K1 and K2 by the method of immunochromatogaphic test (ICT). The invention relates to a test reagent for a Klebsiella pneumoniae strain K1/K2. 'Characteristics comprising a carrier on which a K. pneumoniae virulence strain K1/K2 200907064 is immobilized. The carrier of the test reagent of the present invention includes, but is not limited to, a nitrocellulose membrane. For the favorable sample flow, the carrier can adhere to the sputum sheet. The label in the assay reagent of the present invention can show the reaction of the antibody with the sample, including but not limited to colloidal gold. The antibody in the test reagent of the present invention is an antibody against any K. cholerae strain K1 and K2 toxic strain, which can be conjugated with colloidal gold to produce a conjugate. In a preferred embodiment, the mouse _a_kpl colloidal gold Sputum (CGC) or mouse-a-kp2 colloidal gold co-host. In the test reagent of the present invention, the colloidal gold and the antibody are combined and coated on the integral diffusible carrier to form a colloidal gasket. The colloidal gold gasket can be adhered to the carrier on one side and adhered to the specimen spacer on the other side. The present invention relates to a method for detecting Krebs is a virulent strain K1/K2 of Klebsiella pneumoniae, comprising (a) providing a sample, and (b) adding the sample to the detection reagent of the present invention, and (c) observing the antibody Whether there is an aggregation reaction with the specimen. In the method of the present invention, the test system Klebsiella pneumoniae strain K1 or K2 forms a solid line at the encounter of the antibody. In the method of the present invention, the test reagent includes a control line to indicate that the reagent is functioning properly. The method of the present invention can be used for any test including, but not limited to, clinical liver and abscess, cerebral ridge 200907064 myeloid or urine test. [Examples] Example 1: The present invention is a rapid test for the development of a virulence strain of Klebsiella K1 and K2 by immunochromatogaphic test (ICT), the steps of which are as follows: (1), Cray Preparation of antiserum against virulence strains of Burdock Κ1 and Κ2: Immunization in mice with low doses of virulence strains of Κ1 and Κ2, and addition of secondary antibody: goat-α-mouse-IgG- HRP (Goat-a-mouse-IgG-HRP) was assayed for its titer by enzyme-linked immunosorbent assay (ELISA), and the resulting antibody was purified by protein A chromatography. (1) Spray film and drying: The purified antiserum (mouse _a_kpi and mouse _a_kp2) was diluted to a nitrocellulose membrane (NC membrane, length 3 〇 cm) after the film spray machine was diluted. After being fixed, it will be placed in a constant temperature and humidity clean room for 24 hours and then subjected to a blocking operation. (B), preparation of colloidal gold: appropriate amount of anti-serum antibody and colloidal gold (25nm) for reaction binding and concentration. The prepared mouse _a_kpi CGC and mouse-a-kp2 CGC were fixed on a glass fiber colloidal gold gasket with a spray volume of 3.〇4/cm by a spray film machine, and TEMP was used in a constant temperature and humidity chamber. =37t:, RH = 5%, dry for 30 minutes. (4) Reagent assembly operation: tear off the protective layer of nitrocellulose membrane (Fig. 1), stick the nitrocellulose membrane (position 1), and press the nitric acid membrane with finger to the abdomen to ensure the tannic acid fiber membrane. Stick firmly. Then peel off the protective layer of the absorbent pad, stick the absorbent pad (position 2), and press the Top pad with your fingertips to ensure that the Top pad is firmly attached. Confirm the top edge of the Top pad and the upper edge of the 200907064 plastic bottom card (4). The body of the body is placed 3) The table is peeled off, and the cut frequency gold gasket is pasted along the upper edge of the protective layer where the sample gasket is nowhere. Pressing the fingertips with your fingertips will press the Lai gold material, and it is true that the gold-plated gasket is not strong. The light-faced golden enamel sheet overlaps with the fiber membrane by 2±1. Finally, the specimen is removed from the protective layer, and the cut specimen is aligned along the lower edge of the bottom card (position 彳), and the fingertips are indeed pressed. The mold sample gasket overlaps with the colloidal gold gasket by 5 ± 2 mm. The above assembly (four) will be carded, and the paper will be cut into the city _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Machine packaging. Example 2: 1. The liver pus and the body should be diluted with physiological food (4) as the specimen of bismuth copper. (If the specimen is brain (four) liquid, urine or other body fluid, it may not need to be diluted. If the specimen is cultivated, it can be cultivated. For bacteria, pick up 2-3 colonies and mix well with physiological saline. 2. Open the wrapping paper of the reagent on the table. Draw the specimen to be tested with a micropipette. The specimen to be tested is dropped into the specimen test area (S-Weu). 3, and then "sucking Na Na touch __ secret pure as an oil (four) 3 drops to be tested specimen specimen area (S_well), 3_5 health _ can be read. 4, the criteria for interpretation are as follows: (1). If only - the red line appears in the c handsome ye. Coffee uine), indicating that the test is normal. However, the specimen is not a Krebs, and even K. pertussis is not the most toxic K1 or K2 strain. 200907064 (2). If there are two «red yokes, _ (4) in c post (four) and another - appear in area i (service e) or zone 2 (4), you can determine that the strain is a strain of Ki or K2. Example 3: Picking strains of three different serotypes (packaged, K2 and coffee 2) test results: the reagent on the left side in the second figure is shown as a strain of Κ1/Κ2 type, and the reagent on the middle side is shown as a phantom strain. On the right side, the test surface is K2 type g strain. The serotyping method of this (10) system was used as a control test, and the results did not find cross-reaction with other serotypes of different serotypes, indicating that the specificity of the reagent was extremely high. [Simple description of the diagram] Figure 1 shows the sequence of reagent assembly. S - page shows the results of strain tests for different serotypes (including magic, ^ & n〇n_K1/K2). [Main component symbol description] 1 nitrocellulose membrane 2 absorbent gasket 3 colloidal gold gasket 4 specimen gasket

Claims (1)

200907064 十、申請專利範園: 1. -種克雷伯氏肺炎桿菌毒性菌株Κ1/Κ2的檢驗試劑,其特徵包括一載 體其上固定抗雷克伯氏肺炎桿菌毒性菌株Κ1/Κ2抗體。 2·如申請第1項之檢驗試劑,其中載體係硝酸纖維媒。 з. 如申請第!項之檢驗試劑,其中該抗體為小膠體金共輕物 (CGC)。 4·如申請第1項之檢驗試劑,其中該抗體為小鼠_吨2膠體金共輛物。 5.如申請第1項之檢驗試劑,其另包括膠體金為標記物。 6♦如申請第5項之檢驗試劑’其中膝體金與抗體已結合並塗附於一體可擴 散載體,形成一膠體墊片。 7·如申請第6項之檢驗試劑,其中該膠體墊片黏附於载體。 8.如申請第7項之檢驗試劑,其另包括檢體墊片,黏附於勝體金塾片。 如申明第8項之檢驗試劑,另包括吸水墊片,黏附於載體。 说-種檢測克雷伯是肺炎桿菌毒性株K1/K2之方法,包括⑻提供一檢體, 及⑼將該檢體加入如申請專纖圍第丄項之檢测試劑,及(c)觀察抗體與 檢體是否有聚集反應。 и. -種檢測克雷伯是肺炎桿菌毒性株K1/K2之方法,包括⑷提供一檢體, 及⑼將該檢體加入如申請專利範圍第5項之檢測試劑,及⑹觀察抗體與 檢體是否有聚集反應。 如申π專利|&圍第11項之方法,其中檢體係克雷伯氏肺炎桿菌毒性菌株 Κ1 ’會於遇到抗體處形成—條實線。 如申明專利細第i!項之方法,其中檢體係克雷伯氏肺炎桿菌毒性菌株 11 200907064 Κ2,會於遇到抗體處形成一條實線。 14. 如申請專利範圍第11項之方法,其中檢驗試劑包括一控制線,用以表示 試劑運作正常。 15. 如申請專利範圍第10或11項之方法,可用於臨床肝膿瘍檢體、腦脊髓液 或尿液檢測。 12 200907064 七、指定代表圖: (一) 本案指定代表圖為:第(一)圖。 (二) 本代表圖之元件符號簡單說明: 1硝酸纖維膜 2吸水墊片 3膠體金墊片 4檢體墊片 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式: 無0 200907064200907064 X. Application for Patent Park: 1. A test reagent for the strain K. pneumoniae virulence strain Κ1/Κ2, which is characterized in that a carrier is immobilized on the anti-K. pneumoniae strain Κ1/Κ2 antibody. 2. The test reagent of claim 1, wherein the carrier is a nitrocellulose medium. з. As requested! The test reagent of the item, wherein the antibody is a small colloidal gold co-light (CGC). 4. The test reagent of claim 1, wherein the antibody is a mouse _ ton 2 colloidal gold co-host. 5. The test reagent of claim 1, which further comprises colloidal gold as a marker. 6♦ If the test reagent of claim 5 is applied, wherein the knee gold and the antibody have been combined and coated in an integral diffusible carrier to form a colloidal gasket. 7. The test reagent of claim 6, wherein the colloidal gasket is adhered to the carrier. 8. If applying for the test reagent of item 7, it also includes a sample gasket, which is adhered to the sturdy body. For example, the test reagent of Item 8 is further included, and the water absorbing pad is attached to the carrier. Said - a method for detecting Krebs is a K. pneumoniae strain K1/K2, comprising (8) providing a sample, and (9) adding the sample to a test reagent such as the application for a special fiber, and (c) observing Whether the antibody and the sample have an aggregation reaction. и. - A method for detecting Krebs is a strain of K. pneumoniae strain K1/K2, comprising (4) providing a sample, and (9) adding the sample to a detection reagent as in claim 5, and (6) observing the antibody and detecting Whether the body has an aggregation reaction. For example, the method of claim π patent|& surrounding the 11th item, wherein the test system Klebsiella pneumoniae virulence strain Κ1 ' will form a solid line at the encounter of the antibody. For example, the method of claiming the patent item i!, wherein the test system Klebsiella pneumoniae strain 11 200907064 Κ2, will form a solid line at the encounter of the antibody. 14. The method of claim 11, wherein the test reagent comprises a control line to indicate that the reagent is functioning properly. 15. For the method of patent application No. 10 or 11, it can be used for clinical liver abscess, cerebrospinal fluid or urine testing. 12 200907064 VII. Designated representative map: (1) The representative representative of the case is: (1). (2) The symbol of the symbol of this representative figure is simple: 1 nitrocellulose membrane 2 absorbent pad 3 colloidal gold gasket 4 sample gasket 8. If there is a chemical formula in this case, please reveal the chemical formula that best shows the characteristics of the invention: 200907064 (本,明 螢j月專利月書 — ※申請案號:*體子。月勿任意更動,※記號部分請勿填寫) ※申請曰期:亀丨〇 %IPC八魅.玉-’气^ 、: ” X L 分類.Li2Ql^r ,^0 6,01) 一 〜竹·、r文/央文) I叫!/ 克雷伯氏物®毒性_K1细快速檢驗試劑及其檢 、申請人:(共1A) 發明名稱:(中文/英文) C/2/^ /X 〇 + — … ~ 〇〇06,⑹(This, Mingyue j month patent month book - ※ Application number: * Body. Do not change any month, please do not fill in the ※ part of the mark) ※ Application period: 亀丨〇%IPC eight charm. Jade-' gas ^ ”: XL classification. Li2Ql^r, ^0 6,01) I~Bamboo·, r文/央文) I called!/ Kleberite® Toxicity _K1 Fine Rapid Test Reagent and its inspection, applicant :(Total 1A) Invention Name: (Chinese / English) C/2/^ /X 〇+ — ... ~ 〇〇06,(6) 姓名或名稱:(中文/英文) 國立陽明大學/ NATIONAL YANG-MING UNIVERSITY 代表人:(中文/英文)吳妍華/ LEE仰,YAN-HWA 住居所或營業所地址:(中文/英文) 11221台北市北投區立農街二段155號/N〇. 155, SEC. 2, UN〇NG ST.,BEIT0U DISTRCT, TAIPEI CITY 11221, TAIWAN (R.O.C.) 國籍:(中文/英文)中華民國/R.O.C. 二、發明人:(共5人) 姓名.(中文/英文) 1·;馬長風/Fung, Chang-Phone 2_ 蕭樑基/Siao, Liang-Ji 3. 張蜂義/Chang, Feng-Yee 4. 林永崇/Lin, Jung-Chung 5·陳德禮/Chen, Te-Li 國籍:(中文/英文) 卜5中華民國/R.o.c. 200907064 (本說明書格式、順序及粗體字, 發明專利說明書 忭妨 順序及粗體字’請勿任意更動,※記號部分請勿填寫) 分類:Name or Name: (Chinese / English) National Yang Ming University / NATIONAL YANG-MING UNIVERSITY Representative: (Chinese / English) Wu Yuhua / LEE Yang, YAN-HWA Residence or Business Office Address: (Chinese / English) 11221 Taipei City North 155, No. 155, Section 2, Nong Nong Street, Civic District 155, SEC. 2, UN〇NG ST., BEIT0U DISTRCT, TAIPEI CITY 11221, TAIWAN (ROC) Nationality: (Chinese/English) Republic of China/ROC II. Invention Person: (5 in total) Name. (Chinese/English) 1·; Ma Changfeng/Fung, Chang-Phone 2_ Xiao Liangji/Siao, Liang-Ji 3. Zhang Beeyi/Chang, Feng-Yee 4. Lin Yongchong/Lin , Jung-Chung 5·Chen Deli/Chen, Te-Li Nationality: (Chinese/English) Bu 5 Republic of China/Roc 200907064 (This specification format, order and bold type, invention patent specification order and bold type please Do not change anything, please do not fill in the ※ mark) Category: ※申請案號: ※申請曰期: 一、發明名稱:(中文/英文) 臂㈣心 克雷伯氏肺炎桿菌毒性菌株K1/K2的快速檢測劑 一、 申請人:(共1人) 姓名或名稱:(中文/英文) 國立陽明大學/ NATIONAL YANG-MING UNIVERSITY 代表人:(中文/英文)吳妍華/ LEE WU,YAN-HWA 住居所或營業所地址:(中文/英文) U221台北市北投區立農街二段155號/N〇. 155, SEC. 2, LIN〇NG ST.,BEITOU DISTRCT,TAIPEI CITY 11221,TAIWAN (R.O.C.) 國籍:(中文/英文)中華民國/R.O.C. 二、 發明人:(共5人) 姓名:(中文/英文) 1. 馮長風/Fung, Chang-Phone ID :F104203272 2. 蕭樑基/Siao,Liang-Ji ID : F131085806 3. 張峰義/Chang, Feng-Yee ID : W100154228 4·林永崇/Lin,Jung-Chung ID : R120879220 5·陳德禮/Chen,Te-Li ID : 1100442529 國籍:(中文/英文) 卜5中華民國/r.〇.c. 200907064 發明專利說明書※Application number: ※Application period: 1. Invention name: (Chinese/English) Arm (4) Rapid detection agent for Klebsiella pneumoniae strain K1/K2 1. Applicant: (1 person in total) Name or Name: (Chinese / English) National Yang Ming University / NATIONAL YANG-MING UNIVERSITY Representative: (Chinese / English) Wu Yuhua / LEE WU, YAN-HWA Residence or business address: (Chinese / English) U221 Taipei Beitou District 155, Section 2, Lian Nong Street / N〇. 155, SEC. 2, LIN〇NG ST., BEITOU DISTRCT, TAIPEI CITY 11221, TAIWAN (ROC) Nationality: (Chinese/English) Republic of China/ROC II. Inventor: (5 in total) Name: (Chinese/English) 1. Feng Changfeng/Fung, Chang-Phone ID: F104203272 2. Xiao Liangji/Siao, Liang-Ji ID: F131085806 3. Zhang Fengyi/Chang, Feng-Yee ID: W100154228 4· Lin Yongchong/Lin, Jung-Chung ID: R120879220 5. Chen Deli/Chen, Te-Li ID: 1100442529 Nationality: (Chinese/English) Bu 5 Republic of China/r.〇.c. 200907064 Invention Patent Specification (本說明書格式、;^序及粗广字,請勿任意更動,※記號部分請勿填寫〕 ※申請案號:7 /'/,/- I ※申請曰期: ※IPC分類: Cl 2 ίκ4ί 〇.〇°^ου 一、發明名稱:(中文/英文) mn1/ C Uh/S^i (2006 Ci 克雷伯氏肺炎桿菌毒性菌株K1/K2快速檢測劑/ RAPID SEROTYPES K1/K2 TEST FOR KLEBSIELLA PNEUMONIAE VIRULENT STAINS 二、 申請人:(共1人) 姓名或名稱中文/英文) 國立陽明大學/ NATIONAL YANG-MING UNIVERSITY 代表人:(中文/英文)吳妍華/ LEE WU, YAN-HWA 住居所或營業所地址:(中文/英文) 11221台北市北投區立農衔二段155號/N0.155, SEC. 2, LIN0NG ST.,BEIT0U DISTRCT,TAIPEI CITY 11221,TAIWAN (R.O.C.) 國籍:(中文/英文)中華民國/R.O.C. 三、 發明人:(共5人) 姓名:(中文/英文) 1·馮長風/Fung, Chang-Phone 2·蕭樑基/Siao, Liang-Ji 3. 張峰義/Chang, Feng-Yee 4, 林永崇/li n, Jung-Chung 5_ 陳德禮/Chen,Te-Li 國籍:(中文/英文) 1-5中華民國/R 0 c.(This manual format, ; ^ sequence and thick and wide words, please do not change any more, ※ Do not fill in the number of the mark] ※ Application number: 7 / '/, /- I ※ Application period: ※ IPC classification: Cl 2 ίκ4ί 〇.〇°^ου I. Name of the invention: (Chinese/English) mn1/ C Uh/S^i (2006 Ci Klebsiella pneumoniae strain K1/K2 rapid test agent / RAPID SEROTYPES K1/K2 TEST FOR KLEBSIELLA PNEUMONIAE VIRULENT STAINS II. Applicant: (1 in total) Name or Name Chinese/English) National Yangming University / NATIONAL YANG-MING UNIVERSITY Representative: (Chinese / English) Wu Yuhua / LEE WU, YAN-HWA Residence or establishment Address: (Chinese/English) 11221 No.155, Section 2, No. 2, Nongguan, Beitou District, Taipei, SEC. 2, LIN0NG ST., BEIT0U DISTRCT, TAIPEI CITY 11221, TAIWAN (ROC) Nationality: (Chinese/English) ) Republic of China / ROC III. Inventor: (5 in total) Name: (Chinese / English) 1 · Feng Changfeng / Fung, Chang-Phone 2 · Xiao Liangji / Siao, Liang-Ji 3. Zhang Fengyi / Chang, Feng-Yee 4 , Lin Yongchong / li n, Jung-Chung 5_ Chen Deli / Chen, Te-Li Nationality :(Chinese / English) 1-5 Republic of China / R 0 c.
TW96129626A 2007-08-10 2007-08-10 Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains TWI384075B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW96129626A TWI384075B (en) 2007-08-10 2007-08-10 Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW96129626A TWI384075B (en) 2007-08-10 2007-08-10 Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains

Publications (2)

Publication Number Publication Date
TW200907064A true TW200907064A (en) 2009-02-16
TWI384075B TWI384075B (en) 2013-02-01

Family

ID=44723282

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96129626A TWI384075B (en) 2007-08-10 2007-08-10 Rapid serotypes k1/k2 test for klebsiella pneumoniae virulent strains

Country Status (1)

Country Link
TW (1) TWI384075B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110499374A (en) * 2019-08-12 2019-11-26 山东农业大学 A kind of triple PCR primer sets, kit and application detecting Klebsiella Pneumoniae

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI772776B (en) 2020-04-09 2022-08-01 美商艾諾斯股份有限公司 A pneumonia detection device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW472148B (en) * 1997-10-18 2002-01-11 Dev Center Biotechnology Test reagents for detecting at least two objects to be tested in sample comprising novel colloid-antibody mixture and preparation process thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110499374A (en) * 2019-08-12 2019-11-26 山东农业大学 A kind of triple PCR primer sets, kit and application detecting Klebsiella Pneumoniae
CN110499374B (en) * 2019-08-12 2020-07-17 山东农业大学 Triple PCR primer group for detecting Klebsiella pneumoniae, kit and application

Also Published As

Publication number Publication date
TWI384075B (en) 2013-02-01

Similar Documents

Publication Publication Date Title
Muthukrishnan Multidrug resistant tuberculosis–Diagnostic challenges and its conquering by nanotechnology approach–An overview
Choi et al. Lateral flow assay based on paper–hydrogel hybrid material for sensitive point‐of‐care detection of dengue virus
US8222046B2 (en) Amplification for solid phase immunoassay
Gupta et al. Recent advances in gold nanoparticle-based lateral flow immunoassay for the detection of bacterial infection
CN108169492A (en) It is a kind of to be used to detect colloidal gold immuno-chromatography test paper strip of bovine rota and its preparation method and application
JP6150559B2 (en) Detection method of Mycoplasma pneumonia
Zou et al. Magneto-plamonic nanoparticles enhanced surface plasmon resonance TB sensor based on recombinant gold binding antibody
Ariffin et al. Lateral flow immunoassay for naked eye detection of Mycobacterium tuberculosis
Ghaleb et al. Assessment of diagnostic techniques of urinary tuberculosis
Braga et al. Entamoeba histolytica and Entamoeba dispar infections as detected by monoclonal antibody in an urban slum in Fortaleza, Northeastern Brazil
Esteban et al. Diagnosis of human trematode infections
WO2019241188A1 (en) Antibody pairs for use in a rapid influenza b diagnostic test
TW200907064A (en) Rapid serotypes K1/K2 test for klebsiella pneumoniae virulent stains
Ehara et al. A novel method for rapid detection of Streptococcus pneumoniae antigen in sputum and its application in adult respiratory tract infections
CN104569389A (en) Kit for typing detection of helicobacter pylori
JP4419020B2 (en) Method for detecting Mycobacterium tuberculosis antigen in body fluid
CN102967705A (en) Kit for classificatory detection of helicobacter pylori
Sudha Tuberculosis diagnosis-an overview to the conventional diagnostic methodology and need for nanodiagnosis
CN112334478A (en) Antibody pairs for rapid influenza a diagnostic tests
CN106687813B (en) IgM sxemiquantitative leptospirosis diagnostic kit
TW201142037A (en) Rapid test reagent for detecting Klebsiella pneumoniae serotypes K1 and used thereof
EP1933148B1 (en) Urinary immunochromatographic multiparameter detection cup
AU2020328849A1 (en) Test system for recognizing legionellae
Patel et al. Nanotechnology in TB Diagnosis
Waites et al. Mycoplasma: immunologic and molecular diagnostic methods